Navigation Links
Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
Date:10/12/2007

Cold Spring Harbor, NY Gregory J. Hannon, Ph.D., Cold Spring Harbor Laboratory (CSHL) professor and Howard Hughes Medical Institute (HHMI) investigator, along with two other young investigators will be the recipients of the Memorial Sloan-Kettering Cancer Centers (MSKCC) 2007 Paul Marks Prize for Cancer Research.

The prize, named after Paul A. Marks, Ph.D., President Emeritus of MSKCC, recognizes significant contributions to the basic understanding and treatment of cancer by scientists no more than 45 years old at the time they are nominated. The winners were selected by a committee chaired by Jeffrey M. Friedman, M.D., Ph.D., a professor at The Rockefeller University. Each receives a medal and share a cash award of $150,000.

It is important to show appreciation for the work of younger scientists while they are still in the early stages of their careers, said Dr. Friedman. The Paul Marks Prize pays tribute to the man for whom it was named by honoring some of the most promising researchers of the next generation.

Dr. Hannon is a leader in the relatively new field of RNA interference (RNAi), a naturally occurring mechanism for regulating the expression of genes (controlling which genes are turned on and turned off in cells). In the laboratory, it is used as a tool to study the function of specific genes, and its being investigated as a therapeutic approach for treating many different diseases, including cancer.

Greg Hannons discoveries have had a broad impact on research related to the field of small RNA biology, said Bruce Stillman, Ph.D., CSHL President. As a leader in the RNAi field, Gregs work has resulted in the identification of a process that can manipulate gene expression, leading to a greater understanding of gene function, and identifying potential therapeutic drug targets.

Dr. Hannon earned his Ph.D. degree in molecular biology from Case Western Reserve University.

The Paul Marks Prize was established in 2001 and is awarded biennially. This years winners Hannon, Angelika Amon, Ph.D., of the Massachusetts Institute of Technology (MIT) and the Howard Hughes Medical Institute (HHMI), and Todd R. Golub, M.D., of the Dana-Farber Cancer Institute, the Broad Institute of Harvard and MIT, and the HHMI will speak about their work at a public symposium held at Memorial Sloan-Kettering Cancer Center on December 6, 2007.

Each investigator we are honoring is already a leader in his or her respective field, said Harold Varmus, M.D., MSKCC President. These scientists have made major contributions to the biological understanding of cancer, shedding light on what causes cancer and offering promising solutions that may someday provide benefits to patients everywhere.

In addition to Dr. Friedman, other members of the selection committee were Joan S. Brugge, PhD, of the Department of Cell Biology at Harvard Medical School; Titia de Lange, PhD, of The Rockefeller University; Stephen J. Elledge, PhD, of the Department of Biochemistry at Baylor College of Medicine; Stephen P. Goff, PhD, of the Department of Microbiology at Columbia University; Alan Hall, PhD, of the Cell Biology Program in the Sloan-Kettering Institute; Scott W. Lowe, PhD, of the Cold Spring Harbor Cancer Center; and William G. Kaelin Jr., MD, of the Dana-Farber Cancer Institute.


'/>"/>

Contact: Jim Bono
bono@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. New gene scanning technology marks a major advance in disease research
3. Novel molecular signature marks DNA of embryonic stem cells
4. Scientists map key landmarks in human genome
5. LEGO-Like building blocks to halt cell growth wins Hebrew University prize
6. Comments, experts and background on the 2006 Nobel Prize in chemistry
7. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
8. Australian wins prestigious prize in biodiversity informatics
9. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
10. Zebrafish may hold key to understanding human nerve cell development
11. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... -- Regen BioPharma Inc. (OTCQB: RGBPP) In a ... a team of scientists in Guangzhou, China ... expression of NR2F6 in patients with early cervical cancer correlates ... cervical cancer tissue as well as in the normal tissue ... interesting study and the first that I am aware of ...
Breaking Biology Technology: